Dr Gregory A Cost, MD | |
19250 Sw 65th Ave, Suite 235, Tualatin, OR 97062-7452 | |
(503) 692-4820 | |
(503) 612-0793 |
Full Name | Dr Gregory A Cost |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 33 Years |
Location | 19250 Sw 65th Ave, Tualatin, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104987635 | NPI | - | NPPES |
149963 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD20424 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Legacy Meridian Park Medical Center | Tualatin, OR | Hospital |
Providence Portland Medical Center | Portland, OR | Hospital |
Legacy Mount Hood Medical Center | Gresham, OR | Hospital |
Legacy Good Samaritan Medical Center | Portland, OR | Hospital |
Adventist Health Portland | Portland, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oregon Clinic Pc | 2860390408 | 319 |
News Archive
In the Huffington Post's "Healthy Living" blog, Ward Cates, president emeritus of FHI 360, examines the HIV treatment cascade, which he says "is crucial both to assuring the individual's health and to achieving the public health goal of an AIDS-free generation."
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
Keeping the mind active may delay symptoms of Alzheimer's disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
In the Huffington Post's "Healthy Living" blog, Ward Cates, president emeritus of FHI 360, examines the HIV treatment cascade, which he says "is crucial both to assuring the individual's health and to achieving the public health goal of an AIDS-free generation."
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
Keeping the mind active may delay symptoms of Alzheimer's disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Oregon Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
In the Huffington Post's "Healthy Living" blog, Ward Cates, president emeritus of FHI 360, examines the HIV treatment cascade, which he says "is crucial both to assuring the individual's health and to achieving the public health goal of an AIDS-free generation."
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
Keeping the mind active may delay symptoms of Alzheimer's disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Ts Billings Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497776488 PECOS PAC ID: 0143201954 Enrollment ID: O20040527000506 |
News Archive
In the Huffington Post's "Healthy Living" blog, Ward Cates, president emeritus of FHI 360, examines the HIV treatment cascade, which he says "is crucial both to assuring the individual's health and to achieving the public health goal of an AIDS-free generation."
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
Keeping the mind active may delay symptoms of Alzheimer's disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gregory A Cost, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Dr Gregory A Cost, MD 19250 Sw 65th Ave, Suite 235, Tualatin, OR 97062-7452 Ph: (503) 692-4820 |
News Archive
In the Huffington Post's "Healthy Living" blog, Ward Cates, president emeritus of FHI 360, examines the HIV treatment cascade, which he says "is crucial both to assuring the individual's health and to achieving the public health goal of an AIDS-free generation."
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
Keeping the mind active may delay symptoms of Alzheimer's disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Dr. Michael Paul Gardner, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 19260 Sw 65th Ave, Suite 400, Tualatin, OR 97062 Phone: 503-692-1200 Fax: 503-692-1220 |